Remix Therapeutics Closes $70 Million Series B Financing ...Middle East

PR Newswire - News
Remix Therapeutics Closes $70 Million Series B Financing
Supports Novel Small Molecule Therapeutic Approach Designed to Reprogram RNA Processing and Modulate Gene Expression CAMBRIDGE, Mass., May 17, 2022 /PRNewswire/ -- Remix Therapeutics (Remix), a biotechnology company developing small molecule therapies designed to reprogram RNA processing...

Hence then, the article about remix therapeutics closes 70 million series b financing was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Remix Therapeutics Closes $70 Million Series B Financing )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News